HK1130252A1 - Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders - Google Patents

Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders

Info

Publication number
HK1130252A1
HK1130252A1 HK09108129.8A HK09108129A HK1130252A1 HK 1130252 A1 HK1130252 A1 HK 1130252A1 HK 09108129 A HK09108129 A HK 09108129A HK 1130252 A1 HK1130252 A1 HK 1130252A1
Authority
HK
Hong Kong
Prior art keywords
treatment
medicaments
disorders
thromboembolitic
prodrug derivatives
Prior art date
Application number
HK09108129.8A
Other languages
English (en)
Inventor
Hans-Georg Lerchen
Ursula Krenz
Karl-Heinz Schlemmer
Elisabeth Perzborn
Joerg Keldenich
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of HK1130252A1 publication Critical patent/HK1130252A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
HK09108129.8A 2006-02-16 2009-09-04 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders HK1130252A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006007146A DE102006007146A1 (de) 2006-02-16 2006-02-16 Aminoacyl-Prodrugs
PCT/EP2007/001135 WO2007093328A1 (de) 2006-02-16 2007-02-06 Aminoacyl-prodrug derivate und arzneimittel zur behandlung von thromboembolischen erkrankungen

Publications (1)

Publication Number Publication Date
HK1130252A1 true HK1130252A1 (en) 2009-12-24

Family

ID=38179935

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09108129.8A HK1130252A1 (en) 2006-02-16 2009-09-04 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders

Country Status (23)

Country Link
US (2) US8101601B2 (xx)
EP (1) EP1987026B1 (xx)
JP (1) JP5225864B2 (xx)
KR (1) KR20080094696A (xx)
CN (1) CN101384585B (xx)
AT (1) ATE440839T1 (xx)
AU (1) AU2007214766B2 (xx)
BR (1) BRPI0708064A2 (xx)
CA (1) CA2642376C (xx)
CY (1) CY1109375T1 (xx)
DE (2) DE102006007146A1 (xx)
DK (1) DK1987026T3 (xx)
ES (1) ES2330689T3 (xx)
HK (1) HK1130252A1 (xx)
HR (1) HRP20090629T1 (xx)
IL (1) IL192987A0 (xx)
PL (1) PL1987026T3 (xx)
PT (1) PT1987026E (xx)
RS (1) RS51190B (xx)
RU (1) RU2435768C2 (xx)
SI (1) SI1987026T1 (xx)
WO (1) WO2007093328A1 (xx)
ZA (1) ZA200806891B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006039589A1 (de) * 2006-08-24 2008-03-06 Bayer Healthcare Ag Aminoacyl-Prodrugs II
DE102007032347A1 (de) * 2007-07-11 2009-01-15 Bayer Healthcare Ag Aminoacyl-Prodrugs
DE102007032345A1 (de) * 2007-07-11 2009-01-15 Bayer Healthcare Ag Aminoacyl-Prodrugs
CN101875655B (zh) * 2009-04-28 2012-05-09 天津药物研究院 氨基苯甲酸衍生物及其制备方法和用途
US7816355B1 (en) 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof
US8971019B2 (en) 2012-03-16 2015-03-03 Avx Corporation Wet capacitor cathode containing an alkyl-substituted poly(3,4-ethylenedioxythiophene)
CN102746287B (zh) * 2012-06-21 2014-05-28 成都苑东药业有限公司 一种恶唑烷酮化合物及其制备方法
RU2015112195A (ru) 2012-12-26 2017-01-31 Уэнбери Лтд. Альдегидное производное замещенных оксазолидинонов
PT2895176T (pt) 2012-12-26 2017-01-27 Wanbury Ltd Intermediário de rivaroxabano e a sua preparação
CN114384185A (zh) * 2022-01-20 2022-04-22 北京航空航天大学 用于检测γ-氨基丁酸含量的试剂在制备诊断静脉流出障碍性疾病的试剂盒中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1196414T3 (da) * 1999-06-25 2003-11-24 Vertex Pharma Prolægemiddel af carbamathæmmer for IMPDH
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
CA2452513A1 (en) * 2001-07-12 2003-01-23 Pharmacia & Upjohn Company Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
US7265140B2 (en) * 2003-09-23 2007-09-04 Pfizer Inc Acyloxymethylcarbamate prodrugs of oxazolidinones
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004002044A1 (de) 2004-01-15 2005-08-04 Bayer Healthcare Ag Herstellverfahren
DE102004062475A1 (de) 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
DE102005047558A1 (de) 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102006039589A1 (de) * 2006-08-24 2008-03-06 Bayer Healthcare Ag Aminoacyl-Prodrugs II

Also Published As

Publication number Publication date
AU2007214766A1 (en) 2007-08-23
RU2435768C2 (ru) 2011-12-10
BRPI0708064A2 (pt) 2011-05-17
SI1987026T1 (sl) 2010-01-29
CA2642376A1 (en) 2007-08-23
HRP20090629T1 (hr) 2010-01-31
EP1987026A1 (de) 2008-11-05
PT1987026E (pt) 2009-10-30
RU2008136769A (ru) 2010-03-27
US20120088761A1 (en) 2012-04-12
IL192987A0 (en) 2009-02-11
ES2330689T3 (es) 2009-12-14
ATE440839T1 (de) 2009-09-15
JP5225864B2 (ja) 2013-07-03
US8334284B2 (en) 2012-12-18
CY1109375T1 (el) 2014-07-02
PL1987026T3 (pl) 2010-03-31
RS51190B (sr) 2010-10-31
AU2007214766B2 (en) 2013-05-02
EP1987026B1 (de) 2009-08-26
DE102006007146A1 (de) 2007-08-23
US20110034453A1 (en) 2011-02-10
ZA200806891B (en) 2010-02-24
DK1987026T3 (da) 2009-11-02
US8101601B2 (en) 2012-01-24
CA2642376C (en) 2014-08-12
CN101384585B (zh) 2012-09-26
DE502007001402D1 (de) 2009-10-08
CN101384585A (zh) 2009-03-11
KR20080094696A (ko) 2008-10-23
WO2007093328A1 (de) 2007-08-23
JP2009526788A (ja) 2009-07-23

Similar Documents

Publication Publication Date Title
HK1130252A1 (en) Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
IL190204A0 (en) Novel polymorphous form and the amrphous form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}methyl)-2-thiophene carboxamide
MY143999A (en) Solid, modified-release pharmaceutical dosage forms which can be administered orally
ECSP066584A (es) Procedimiento para la producción de una composición farmacéutica sólida de administración oral
HK1157759A1 (en) New co-crystal compound of rivaroxaban and malonic acid
MX2009001977A (es) Derivados profarmacologicos de aminoacilo y medicamentos para el tratamiento de enfermedades tromboembolicas.
MY138944A (en) Preparation process
WO2007039122A3 (de) Feste, oral applizierbare pharmazeutische darreichungsformen mit schneller wirkstofffreisetzung
TN2014000541A1 (en) Pharmaceutical administration forms comprising 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
PH12015501625A1 (en) Aldehyde derivative of substitute oxazolidinones
WO2012080184A3 (de) Flüssige, oral applizierbare pharmazeutische zusammensetzungen enthaltend 5-chlor-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
CU23445A3 (es) Procedimiento de preparación
DOP2004001034A (es) Procedimiento para la preparacion de una composicion farmaceutica solida administrable oralmente que comprende 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida en forma hidrofilizada
UY28628A1 (es) Procedimiento para la preparación de una composición farmacéutica sólida administrable oralmente
UY29305A1 (es) Formas de dosificación farmacéutica sólidas administrables por vía oral con liberación modificada
DOP2004001066A (es) Procedimiento de preparacion

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180206